Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes.

International Journal of Clinical Practice
S A Jabbour, B J Goldstein

Abstract

The kidney plays a central role in the regulation of plasma glucose levels, although until recently this has not been widely appreciated or considered a target for therapeutic intervention. The sodium glucose co-transporter type 2 (SGLT2) located in the plasma membrane of cells lining the proximal tubule mediates the majority of renal glucose reabsorption from the tubular fluid, which normally prevents the loss of glucose in the urine. Competitive inhibitors of SGLT2 that provoke the renal excretion of glucose have been discovered, thereby providing a unique mechanism to potentially lower the elevated blood glucose levels in patients with diabetes. To explore the physiology of SGLT2 action and discuss several SGLT2 inhibitors that have entered early clinical development. All publicly available data were identified by searching the internet for 'SGLT2' and 'SGLT2 inhibitor' through 1 November 2007. Published articles, press releases and abstracts presented at national and international meetings were considered. Sodium glucose co-transporter type 2 inhibition is a novel treatment option for diabetes, which has been studied in preclinical models and a few potent and selective SGLT2 inhibitors have been reported and are currently i...Continue Reading

References

Nov 14, 1998·The American Journal of Physiology·E M Wright
Dec 29, 2000·Diabetes Care·S E GeerlingsUNKNOWN Diabetes Women Asymptomatic Bacteriuria Utrecht Study Group
Sep 25, 2003·Journal of Cellular Biochemistry·Lubing ZhouKeith T Demarest
Oct 22, 2003·Journal of the American Society of Nephrology : JASN·René SanterDan Klaerke
Sep 24, 2004·Bioorganic & Medicinal Chemistry Letters·Joseph DudashKeith T Demarest
Nov 17, 2004·Current Medicinal Chemistry·Tomoichiro AsanoYasunobu Uchijima
Dec 30, 2004·Diabetes/metabolism Research and Reviews·Joel R L EhrenkranzJesse Roth
Apr 13, 2005·Lancet·Michael StumvollTimon W van Haeften
Dec 29, 2005·Bioorganic & Medicinal Chemistry Letters·Xiaoyan ZhangKeith T Demarest
Jan 18, 2006·Drug Metabolism and Pharmacokinetics·Masuhiro Nishimura, Shinsaku Naito

❮ Previous
Next ❯

Citations

Dec 6, 2011·Naunyn-Schmiedeberg's Archives of Pharmacology·Atsuo TaharaMasayuki Shibasaki
Oct 2, 2009·Current Diabetes Reports·Clifford J Bailey
Apr 29, 2010·Current Diabetes Reports·Anupa K Patel, Vivian Fonseca
Jan 21, 2012·American Journal of Physiology. Cell Physiology·Ivan SabolicHermann Koepsell
Oct 4, 2013·Chemical & Pharmaceutical Bulletin·Shigeki SakamakiSumihiro Nomura
Mar 5, 2013·Expert Opinion on Investigational Drugs·William N Washburn, Simon M Poucher
Feb 3, 2015·Expert Opinion on Drug Metabolism & Toxicology·Maka S Hedrington, Stephen N Davis
Sep 13, 2015·Biochemical Pharmacology·I DardiS A Jabbour
Nov 12, 2009·Pharmacological Reports : PR·Aleksandra Bołdys, Bogusław Okopień
Mar 5, 2011·Kidney International. Supplement·Masayuki Isaji
Mar 1, 2010·The EPMA Journal·Cristina M SenaRaquel Seiça
Aug 6, 2013·Journal of Clinical Pharmacy and Therapeutics·S CangozR B Raffa
Jan 30, 2013·The Journal of Pharmacy and Pharmacology·Monika Misra
May 6, 2011·Journal of Clinical Pharmacology·Raktim Kumar GhoshSarfaraz Abdeli Jasdanwala
Mar 3, 2010·Pharmazie in unserer Zeit·Ramona Steri, Manfred Schubert-Zsilavecz
Jul 1, 2015·Metabolic Syndrome and Related Disorders·Kayla RiggsAbsalon D Gutierrez
Feb 27, 2013·Renal Failure·Aaishwarya B DeshmukhBharat Mishra
Jul 30, 2009·Diabetes Care·Stephanie A Amiel
Nov 5, 2010·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·R Sabino-SilvaU F Machado
Apr 4, 2017·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xiaojing WangXinhua Xiao
Jul 9, 2009·The Annals of Pharmacotherapy·Amie McCord Brooks, Stacey M Thacker
May 10, 2017·Clinical Pharmacology and Therapeutics·E LioudakiE S Ganotakis
Oct 5, 2017·Revista da Associação Médica Brasileira·Leyna Leite SantosFabiano Timbó Barbosa
Feb 3, 2015·Chemistry : a European Journal·Karel HernándezPere Clapés
Jan 4, 2019·Circulation Research·Helena C Kenny, E Dale Abel
Feb 2, 2013·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sarah A NislyAlison M Walton
Mar 31, 2010·Nature Reviews. Nephrology·Amanda Mather, Carol Pollock
May 29, 2010·Nature Reviews. Drug Discovery·Edward C Chao, Robert R Henry
Jun 15, 2018·Surgical Neurology International·Leopoldo Luciano LuqueJorge Lambre
Feb 19, 2009·American Journal of Physiology. Endocrinology and Metabolism·Armelle LeturqueMaude Le Gall
Oct 17, 2009·American Journal of Therapeutics·Zafar H Israili

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.